Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUPREMA trial of ropivacaine field infiltration in breast-conserving surgery
NL-OMON22294Recruiting
- Sponsor
- Reinier de Graaf Apotheek
- Start
- Oct 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in breast cancer comparing Ropivacaine infiltration plus general anesthesia with Placebo infiltration plus general anesthesia (2 arms). Primary endpoint: Postoperative vomiting within 24 hours. Started Oct 2007; status: recruiting.
02
Drugs
ropivacaine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NL-OMON22294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22294.